AEQUILIBRIUM PHARMA S.r.l. is a significant supplier to the pharmaceutical industry, specialising in Active Pharmaceutical Ingredients (APIs), Contract Manufacturing (CMO/CDMO), and tailored solutions for drug development. The company is engaged in the production of biosimilars, monoclonal antibodies, and antibody-drug conjugates, as well as innovative methodologies such as Agrobacterium-mediated transient expression to enhance its offerings. With a strong focus on biotechnology, AEQUILIBRIUM PHARMA S.r.l. develops products including Bevacizumab and Trastuzumab, serving as a pivotal partner in the creation of advanced therapies, including vaccines for infectious diseases like COVID-19.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Protein and Peptide
- Cell and Gene Therapy

AEQUILIBRIUM PHARMA S.r.l. continues to bolster its reputation in the pharmaceutical sector by delivering comprehensive services that meet the evolving needs of its clients. For more information, please visit aeqpharma.com.